Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases

Table 3 Alterations in serum IGF-1, osteocalcin and PTH levels according to the severity of the disease from class A to C (mean ± SE)

Severity	A	B	C	LSD at 0.05
	(n = 24)	(n = 22)	(n = 4)
IGF-1	152.6b± 7	186.8a± 20.3	196.0a± 36.4	32.67
(ng/mL)
Osteocalcin	12.6b± 0.9	14.6a± 0.9	15.8a± 1.2	1.73
(ng/mL)
PTH	71.3b± 3.0	70.3b± 2.7	86.5a± 4.3	5.36
(ng/mL)

Within each row the means followed by different letters are significantly different. LSD: Least significance difference.

^aP < 0.05,

^bP < 0.01 vs control group.